Background Calcification is a frequent cause of the clinical failures of glutaraldehyde-pretreated bioprosthetic heart valves (BPHV) fabricated from glutaraldehyde-cross-linked porcine aortic valves. 2-Amino oleic acid (AOA) has been shown in previous in vivo studies to be a promising anticalcification agent. Our objective was to investigate the mechanism of calcification inhibition mediated by AOA pretreatment of porcine aortic valve bioprostheses.
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Methods and Results BPHV tissues were treated with an AOA solution for 72 hours before experimentation. The diffusion of AOA across both cusp and aortic wall was evaluated. The lag time for AOA to diffuse across the aortic wall was prolonged compared with that of the cusp. An extraction study was performed to determine the stability of AOA binding; the results indicated that the binding was relatively stable regardless of solvent extraction conditions. The interaction between ionic calcium and AOA on treated tissue also was investigated by evaluating the patterns of calcium diffusion across both treated and untreated tissues.
C alcific degeneration causes most clinical failures of bioprosthetic heart valve (BPHV) replacements fabricated from porcine aortic valves cross-linked with glutaraldehyde.1 Procedures for inhibiting BPHV calcification have been investigated in animal model studies involving either subdermal implants in rats2 or circulatory implants in large animals (sheep or calves).3-8 Thus far, of all the inhibition strategies studied including pretreatments with diphosphonate or metallic salt solutions, polymer incorporation into leaflet structures, and others, only detergent pretreatments have inhibited calcification in both subdermal and circulatory animal model studies. The mechanism of action of detergent pretreatment for inhibiting bioprosthetic calcification is incompletely understood at present. The present investigations focused on a bio-prosthetic pretreatment procedure using a detergent, 2-amino oleic acid (AOA), which has been hypothesized to covalently bond to aldehyde residuals and thus remain within pretreated bioprosthetic tissue, sustaining its calcification inhibition effects.
It was previously demonstrated in a study of porcine bioprosthetic leaflets implanted subdermally in rats7 and a series of sheep orthotopic mitral valve replacements8 that AOA mitigates calcification of BPHV. AOA is hypothesized to bind by its 2-amino group to free aldehyde groups of tissue bound glutaraldehyde (a Schiff base reaction9-11), thus allowing AOA to remain in the tissue. Although AOA was shown to be effective in reducing the level of bioprosthetic mineralization in animal models, its long-term binding stability might not be adequate because of the known reversibility of the Schiff base reaction.9-1" 
Diffusion of Calcium Across Tissues
The thicknesses of all cusp samples were measured before experimentation as described above. A piece of AOA-treated cusp tissue was mounted on a microdiffusion cell. One milliliter of 0.2% (18 mol/L) calcium chloride solution was pipetted into the donor chamber, and 1 mL of water was immediately added to the recipient chamber. The diffusion cell was placed on a shaker rotating at 150 rpm; temperature was maintained at 37°C. After 
Calcium Analysis of Explanted Bioprosthetic Tissues
Fifteen sheep were used for valve implantation: seven of them received AOA-pretreated, stentless valves, and the rest received control valves (ie, non-AOA-pretreated). Representative samples (one sample from each leaflet and adjacent aortic wall tissues) from 150-day sheep valved grafts (implanted as left ventricular apicoaortic shunt) were assessed upon retrieval by one of us (F.J.S.) as part of an investigation of the hemodynamic performance and calcification inhibition of AOA pretreated bioprosthetic heart valves. 16 Retrieved aortic cusps and aortic wall samples were separately analyzed for calcium as detailed below. Cuspal and aortic wall tissues were lyophilized, weighed, and acid hydrolyzed according to established procedures.17'18 Tissue calcium contents were determined by atomic absorption spectroscopy at a wavelength of 422.8 nm. ANOVA was used to test statistical significance.
Results

AOA Diffusion
When glutaraldehyde-cross-linked porcine aortic valve tissue was used as a diffusion barrier (Fig 1A) , a significant amount of AOA (> 1% of the AOA from the donor chamber) penetrated the tissue after only 1 hour. The results of AOA diffusion across cusp tissue and aortic wall are illustrated in Fig 1A and 1B, respectively ; the corresponding diffusion lag times and thicknesses are summarized in Table 1 . The tissue thickness and the lag time determined were 0.73±0.11 mm and 0.56 hour, respectively. When aortic wall was used as a diffusion barrier (Fig 1B) , the time required to detect a significant amount of AOA (>1% of the AOA from the donor chamber) drastically increased to about 48 hours. The corresponding tissue thickness and extrapolated lag 
Stability of AOA Binding
Extraction studies of AOA-treated tissues (cusp and aortic wall) were performed to determine the stability of AOA binding. Initially, pH 7.4 phosphate buffer was used as a medium for the study. To better simulate the in vivo environment that a BPHV valve would encounter after implantation, an AOA extraction study was also conducted using bovine serum as an alternative medium. Furthermore, the poor solubility of AOA in water and hence in phosphate buffer may thus reflect its dissolution characteristics rather than its binding stability. Therefore, Tween-80, a nonionic surfactant, was used as a harsh dissociative medium to forcibly enhance nonbound AOA dissociation.
The results of the 1-month extraction study using both cusp and aortic wall are illustrated in Fig 2A and  2B , respectively. In general, an initial burst followed by a greatly diminished rate of AOA extraction was observed in each study. The rate of extraction in phosphate buffer began to plateau at 24 hours compared with that of Tween-80, which leveled off within 8 hours. As illustrated in Fig 2A, using Tween-80 as the extraction medium, approximately 60% of the AOA was lost from the cusps after the first 12 hours. Although a similar pattern was observed with aortic wall (Fig 2B) , a significant amount of AOA was found to remain on this tissue as well at the conclusion of the study. exhaustive washing protocol described above followed by freeze drying. Nevertheless, the results of the bovine serum studies were highly reproducible (as shown) and internally consistent, suggesting high levels of AOA residual tissue binding after serum exposure.
Calcium Diffusion
The results of calcium diffusion across cusp (AOApretreated and untreated) and aortic wall (AOA-pre- §Each number represents at least five replicates ±SEM. AOA levels on both types of tissue after the extraction study were significantly lower than those of controls (P<.001 in both cases). treated and untreated) tissues are depicted in Fig 3. In Fig 3A, after 1 hour of diffusion, the cumulative amounts of calcium diffused across the AOA-pretreated and untreated cusp tissues were 33.1±1.7 and 78.2± 3.8 ,ug, respectively. Their corresponding diffusivities are 2.69±0.11 and 1.25±0.05 mm2/h. When aortic wall was used as a diffusion barrier (Fig 3B) , the cumulative amount of calcium diffused across the AOA-pretreated and untreated tissues was 9.0±1.7 and 14.0±1.6 pg, respectively, after 24 In our calcium diffusion studies, the presence of AOA on bioprosthetic tissue greatly reduced the immediate calcium ion influx. Therefore, covalently linked AOA could hypothetically retard the kinetics of initiating crystalline calcium phosphate formation in part by a similar mechanism. The low abundance of initial nucleation sites hinders further crystallization of calcium Moreover, the phospholipids (and thus its phosphate groups) in cell membranes also could serve as sites for attracting calcium ion, which could in turn result in initiating the process of calcification. AOA also could function as a surfactant to extract and perhaps exchange the phospholipid. This may thereby lessen the sites available for calcification.
Stability of AOA Binding to Tissues
The results of the extraction study demonstrated that a significant level of AOA remained bound despite harsh solvent conditions. Thus, the hypothesized aminoresidual aldehyde bonding mechanism is supported by these results. Alternatively, AOA affinity (nonextractability) could be due to hydrogen bonding or nonspecific hydrophobic adsorption. Definitive The effectiveness of AOA also should be viewed with the perspective of other experimental anticalcification strategies. Pretreating bioprostheses with sodium dodecyl sulfate (SDS) in sheep circulatory implants,31 aluminum chloride and ferric chloride20 in rat subdermal studies, and diphosphonate compounds (eg, aminodiphosphonate) in rat subdermal studies22 has proven to be efficacious. Interestingly, aortic wall calcification has not been assessed in prevention studies except for subdermal implant experiments in which A3I and Fe3ì on and aminodiphosphonate all inhibited aortic wall calcification.32 In comparison to other detergents, the level of inhibition by AOA of cuspal calcification was either comparable or superior to the most optimal results reported previously,28 which were obtained using either SDS-or polysorbate 80-pretreated bioprosthetic heart valves as orthotopic mitral valve replacement in sheep.28 Furthermore, other detergents effective for preventing calcification such as n-lauryl-sarcosine or Triton X-100 resulted in primary material failure caused by destabilization of bioprosthetic tissue. 28 Thus, it is possible to speculate that a sequential application of optimal anticalcification agents such as AOA (and others) to treat BPHV before implantation could be a rational approach for compensation of limitation(s) of each agent, and this multiagent approach of BPHV treatment may result in a synergistic anticalcification effect for both aortic wall and valve. Conclusions AOA was demonstrated to be tightly associated to glutaraldehyde-pretreated BPHV tissue, possibly the result of an aldehyde-amino reaction, and AOA association stability was demonstrated despite various strenuous solvent extractions. AOA pretreatment diminished Ca2' diffusion into bioprosthetic tissues. This may explain in part the anticalcification mechanism of AOA. Furthermore, sheep explant analyses demonstrated that AOA preincubation was an effective means for inhibiting the calcification of glutaraldehyde-pretreated porcine aortic valve cusps but not aortic wall.
